Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction (Q36304237)

13 August 2017

1 reference

title

Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction (English)

1 reference

13 August 2017

1 reference

myocardial infarction

1 reference

Richard O Cannon

1

1 reference

13 August 2017

1 February 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

88-94

1 reference

13 August 2017

2

1 reference

Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Apoptosis in myocardial ischaemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Protective responses in the ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Activation of mitochondrial ATP-dependent potassium channels by nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

A novel protective effect of erythropoietin in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Cardioprotective effects of 70-kDa heat shock protein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Small heat shock proteins and protection against ischemic injury in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

The stunned myocardium: prolonged, postischemic ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Myocardial protection at a crossroads: the need for translation into clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Cardiac protection during acute myocardial infarction: where do we stand in 2004?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Widespread Myocardial Inflammation and Infarct-Related Artery Patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Cellular and molecular dissection of reperfusion injury: ROS within and without

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Reperfusion induces myocardial apoptotic cell death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Apoptosis in human acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Nitric Oxide Inhibits Caspase-3 byS-Nitrosationin Vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Prolonged abnormalities of left ventricular diastolic wall thinning in the "stunned" myocardium in conscious dogs: time course and relation to systolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium"

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardi

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0096

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0096

1 reference

13 August 2017

1 reference

PubMed ID

16265379